The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Rash in Multicenter Trials of Lamotrigine in Mood Disorders: Clinical Relevance and Management
Abstract
BACKGROUND: The rate of lamotrigine-associated rash in patients with mood disorders has not been well characterized. The objective of this report was to determine rash rates in clinical trials of lamotrigine in DSM-IV unipolar depression or bipolar disorder. METHOD: A retrospective analysis was conducted of rates of lamotrigine-related rash in 12 multicenter studies, including 1 open study, 7 randomized controlled acute trials, and 4 randomized controlled maintenance trials from 1996 to 2001. RESULTS: A total of 1955 patients were treated with lamotrigine in open-label settings (open-label phases preceding or following randomization and 1 stand-alone open-label study); 1198 patients received lamotrigine in controlled settings, and 1056 patients received placebo. In controlled settings, rates of benign rash were 8.3% and 6.4% in lamotrigine- and placebo-treated patients, respectively. Rates of serious rash were 0% with lamotrigine, 0.1% (N = 1) with placebo, and 0% with comparators. In the open-label setting, the overall rate of rash for lamotrigine was 13.1% (N = 257) and of serious rash, 0.1% (N = 2). One mild case of Stevens-Johnson syndrome not requiring hospitalization occurred in a patient treated with lamotrigine. There were no cases of toxic epidermal necrolysis in any setting. CONCLUSION: Serious drug eruptions associated with lamotrigine were rare. Although rash is a potentially life-threatening reaction, the risk of serious rash due to lamotrigine should be weighed against more common risks associated with untreated or undertreated bipolar depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Shear, N. H., & Spielberg, S. P. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113798 · Cited by 687
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1106 · Cited by 498
Self-citationA Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Self-citationAnticonvulsant Hypersensitivity Syndrome
Vittorio, C. C. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.21.2285 · Cited by 436
Toxic epidermal necrolysis (Lyell syndrome)
Roujeau, J.-C., Chosidow, O., Saiag, P., & Guillaume, J.-C. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70333-d · Cited by 383
Rzany, B., Correia, O., Kelly, J. P., Naldi, L., Auquier, A., & Stern, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05418-x · Cited by 348
Lamotrigine‐Associated Rash: Risk/Benefit Considerations in Adults and Children
Guberman, A. H., Besag, F. M. C., Brodie, M. J., Dooley, J. M., Duchowny, M. S., Pellock, J. M., Richens, A., Stern, R. S., & Trevathan, E. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00807.x · Cited by 339
Anticonvulsant Hypersensitivity Syndrome: Incidence, Prevention and Management
Knowles, S. R., Shapiro, L. E., & Shear, N. H. (1999) · Drug Safety · doi:10.2165/00002018-199921060-00005 · Cited by 303
Safety Review of Adult Clinical Trial Experience with Lamotrigine
Messenheimer, J., Mullens, E. L., Giorgi, L., & Young, F. (1998) · Drug Safety · doi:10.2165/00002018-199818040-00004 · Cited by 252
Antiepileptic Drug Hypersensitivity Syndrome
Schlienger, R. G., & Shear, N. H. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01678.x · Cited by 171
Spectrum of Activity of Lamotrigine in Treatment-Refractory Bipolar Disorder
Calabrese, J. R., Bowden, C. L., McElroy, S. L., Cookson, J., Andersen, J., Keck, Jr., Rhodes, L., Bolden-Watson, C., Zhou, J., & Ascher, J. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1019 · Cited by 167
Self-citationFactors Influencing the Incidence of Lamotrigine-Related Skin Rash
Wong, I. C. K., Mawer, G. E., & Sander, J. W. A. S. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18422 · Cited by 130
Lamotrigine Compared with Lithium in Mania: A Double-Blind Randomized Controlled Trial
Ichim, L., Berk, M., & Brook, S. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009066725103 · Cited by 114
Adding Lamotrigine to Valproate: Incidence of Rash and Other Adverse Effects
Faught, E., Morris, G. L., Jacobson, M. P., French, J. A., Harden, C. L., Montouris, G., Rosenfeld, W. E., & Postmarketing Antiepileptic Drug Survey (PADS) Group (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00831.x · Cited by 102
Rechallenge with lamotrigine after initial rash
Tavernor, S., Wong, I. C. K., Newton, R., & Brown, S. W. (1995) · Seizure · doi:10.1016/s1059-1311(05)80082-2 · Cited by 66
Successful re-introduction of lamotrigine after initial rash
Besag, F., Ng, G. Y. T., & Pool, F. J. (2000) · Seizure · doi:10.1053/seiz.2000.0394 · Cited by 42
Cited by
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationA Review of Postpartum Psychosis
Sit, D., Rothschild, A. J., & Wisner, K. L. (2006) · Journal of Women's Health · doi:10.1089/jwh.2006.15.352 · Cited by 454
Yatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., Sharma, V., Silverstone, P., Alda, M., Baruch, P., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00219.x · Cited by 388
Suppes, T., Dennehy, E. B., Hirschfeld, R. M. A., Altshuler, L. L., Bowden, C. L., Calabrese, J. R., Crismon, M. L., Ketter, T. A., Sachs, G. S., Swann, A. C., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0710 · Cited by 330
Self-citationComparison and predictors of rash associated with 15 antiepileptic drugs
Arif, H., Buchsbaum, R., Weintraub, D., Koyfman, S., Salas-Humara, C., Bazil, C. W., Resor, S. R., & Hirsch, L. J. (2007) · Neurology · doi:10.1212/01.wnl.0000261917.83337.db · Cited by 277
Metadata
- Authors
- Calabrese, J. R., Sullivan, J. R., Bowden, C. L., Suppes, T., Goldberg, J. F., Sachs, G. S., Shelton, M. D., Goodwin, F. K., Frye, M. A., & Kusumakar, V.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-11-15
- Volume
- 63
- Issue
- 11
- Pages
- 1012-1012
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1967735031
- Cited by
- 334
- References
- 18
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.